CLINICAL_TRIALS
trial_result
· 2017-09-21
Clinical Trial Update: Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia [Phase 4]
Summary
Phase 4 trial evaluating intranasal oxytocin effects on satiety signaling in people with schizophrenia; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2017-09-21